Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination

Vaccine

Volumn 26, Issue 1, 2007, Pages 59-66

  Cohen, Bernard J ^a   Audet, Susette ^b   Andrews, Nick ^a   Beeler, Judy ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Measles; Plaque reduction neutralization test

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

AEROSOL; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DISEASE MARKER; HUMAN; IMMUNOGENICITY; LICENSING; NONHUMAN; PLAQUE REDUCTION NEUTRALIZATION TEST; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SERODIAGNOSIS; STANDARD; VACCINATION; VALIDATION PROCESS;

AEROSOLS; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; MEASLES VACCINE; NEUTRALIZATION TESTS; PLAQUE ASSAY; STATISTICS AS TOPIC; VACCINATION; VERO CELLS;

EID: 36749043225     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.046     Document Type: Article

References (20)

1. Moss W.J., and Griffin D.E. Global measles elimination. Nat Rev Microbiol 4 12 (2006) 901-908
2. World Health Organisation. Proceedings of the fifth global vaccine research forum. Montreux, Switzerland, June 7-10 (2004)
3. Valdespino-Gómez J.L., Garcia-Garcia M.d.L., Fernandez-de-Castro J., Henao-Restrepo A.M., Bennett J., and Sepulveda-Amor J. Measles aerosol vaccination. Curr Top Microbiol Immunol 304 (2006) 165-193
4. Low N, Kraemer S, Martin M, Henao Restrepo AM. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis, Vaccine, accepted for publication.
5. Griffin D.E. Measles virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 1401-1441
6. Albrecht P., Herrman K., and Burns G.R. Role of virus strain in conventional and enhanced measles plaque neutralisation test. J Virol Methods 3 5 (1981) 251-260
7. Cohen B.J., Parry R.P., Doblas D., Samuel D., Warrener L., Andrews N., et al. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay. J Virol Methods 131 2 (2006) 209-212
8. Forsey T., Heath A.B., and Minor P.D. The 1st International Standard for anti-measles serum. Biologicals 19 3 (1991) 237-241
9. World Health Organization. Report of a collaborative study to assess the suitability of a replacement for the 2nd International Standard for anti-measles serum. Expert Committee on Biological Standardization, Geneva, October 23-27, 2006, WHO/BS/06.2031.
10. Grist N.R., Ross C.A.C., Bell E.J., and Stott E.J. Diagnostic Methods in Clinical Virology (1996), Blackwell Scientific Publications, Oxford
11. Health Protection Agency, Plaque reduction neutralisation (PRN) assay for measles antibodies: modified standard operating procedure for WHO studies of aerosol vaccination. Retrieved from http://www.hpa.org.uk/cfi/vrd/idu/default.htm (February 2007).
12. European Medicines Agency Committee for Human Medicinal Products (CHMP). Note for guidance on clinical evaluation of vaccines; 2005, CHMP/VWP/164653/2005.
13. Horne A.D., Lachenbruch P.A., Getson P.R., and Hsu H.S. Analysis of studies to evaluate immune response to combination vaccines. Clin Infect Dis 33 Suppl. 4 (2001) S306-S311
14. World Health Organization 2004, Technical Report Series, 924, Annex 1 Guidelines on clinical evaluation of vaccines: regulatory expectations.
15. Chen R.T., Markowitz L.E., Albrecht P., Stewart J.A., Mofenson L.M., Preblud S.R., et al. Measles antibody: reevaluation of protective titers. J Infect Dis 162 5 (1990) 1036-1042
16. Chen R., Mofenson L., Albrecht P., Page P., Orenstein W., and Etkind P. Protective measles antibody titres in college students. Presented at the 35th annual Epidemic Intelligence Service conference. Atlanta, April 14-18 (1986)
17. Markowitz L.E., Sepulveda J., Diaz-Ortega J.L., Valdespino J.L., Albrecht P., Zell E.R., et al. Immunization of 6-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med 322 9 (1990) 580-587
18. Gans H.A., Yasukawa L.L., Alderson A., Rinki M., DeHovitz R., Beeler J., et al. Humoral and cell-mediated immune responses to an early two-dose measles vaccination regimen in the United States. J Infect Dis 190 1 (2004) 83-90
19. Caceres V.M., Strebel P.M., and Sutter R.W. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 31 1 (2000) 110-119
20. Lee M.S., Cohen B.J., Hand J., and Nokes D.J. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody. J Virol Methods 78 1-2 (1999) 209-217